Narendra Kumar B. Patel
22Patents
8h-index
27Co-inventors
71Inventor score
Filing activity: Apr 6, 2010 → Dec 6, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8263596B2 | Kinase inhibitors and method of treating cancer | Chemistry; Metallurgy | 18 | Active |
| US8481533B2 | Kinase inhibitors and method of treating cancer | Chemistry; Metallurgy | 17 | Active |
| US8481525B2 | Kinase inhibitors and method of treating cancer with same | Chemistry; Metallurgy | 17 | Active |
| US8921545B2 | Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones | Chemistry; Metallurgy | 15 | Active |
| US9139563B2 | Kinase inhibitors and method of treating cancer | Chemistry; Metallurgy | 14 | Active |
| US8999968B2 | Kinase inhibitors and method of treating cancer with same | Chemistry; Metallurgy | 13 | Active |
| US9573954B2 | Pyrazolopyrimidine compounds | Chemistry; Metallurgy | 12 | Active |
| US9657025B2 | Pyrazolopyrimidine compounds | Chemistry; Metallurgy | 11 | Active |
| US9907800B2 | Kinase inhibitors and method of treating cancer | Chemistry; Metallurgy | 6 | Active |
| US9579327B2 | Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones | Chemistry; Metallurgy | 5 | Active |
| US10358436B2 | Kinase inhibitors and method of treating cancer | Chemistry; Metallurgy | 4 | Active |
| USRE47731E1 | Kinase inhibitors and method of treating cancer with same | General | 4 | Active |
| US9796703B2 | Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones | Chemistry; Metallurgy | 4 | Active |
| US10106545B2 | Pyrazolopyrimidine compounds | Chemistry; Metallurgy | 3 | Active |
| US10077255B2 | Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones | Chemistry; Metallurgy | 2 | Active |
| US11072616B2 | Cyclic peptides targeting alpha-4-beta-7 integrin | Emerging Cross-Sectional Technologies | 2 | Active |
| US10501474B2 | HPK1 inhibitors and methods of using same | Human Necessities | 2 | Active |
| US10570143B2 | Pyrazolopyrimidine compounds | Chemistry; Metallurgy | 2 | Active |
| US10167289B2 | Pyrazolopyrimidine compounds | Chemistry; Metallurgy | 2 | Active |
| US11059832B2 | HPK1 inhibitors and methods of using same | Human Necessities | 0 | Active |
| US11260055B2 | Oral pharmaceutical composition of lurasidone and preparation thereof | Human Necessities | 0 | Active |
| US9580390B2 | Indazole compounds as kinase inhibitors and method of treating cancer with same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.